Cannabis Law Report

NOVEMBER 22, 2021

Thailand’s Public Health Ministry has signed a Memorandum of Understanding (MOU) with RxLeaf World Medica on establishing the International Medical Cannabis Research Center. The latest movement is a part of Thailand’s plan to be a world-class cannabis production and development hub. For more information [link].

Research and Development 52

Research and Development Epilepsy Cannabis Food 52

MMJ Recs

FEBRUARY 3, 2024

In recent years, the landscape of medical marijuana laws has evolved, presenting new opportunities and challenges for patients, healthcare providers, and industry stakeholders. These laws outline the parameters for the cultivation, distribution, and use of medical cannabis within the city.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

JANUARY 15, 2019

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Epilepsy 71

Epilepsy Cannabinoids Treatment Research and Development 71

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Effective, most effective in treatment Relieve symptoms.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

United Patients Group

JULY 7, 2023

While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

MMJ Recs

JUNE 9, 2024

The program was enacted into law in April 2017 with the passage of the West Virginia Medical Cannabis Act. Qualifying conditions include chronic or debilitating diseases, including cancer, epilepsy, multiple sclerosis, Crohn’s disease, Parkinson’s disease, and post-traumatic stress disorder (PTSD), among others.

Access 52

Access Marijuana Patients Programs 52

Veriheal

DECEMBER 8, 2023

The new law officially kicks in today, December 7th. This crease in the law essentially acknowledges that while THC can indicate impairment, THC stored in the body long after consumption does not mean one is CURRENTLY impaired. The new law also has a number of other exceptions. to embrace recreational cannabis.

Recreational 104

Recreational Research and Development Epilepsy THC 104

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

MMJ Recs

MARCH 28, 2024

With evolving laws and regulations, finding the right MMJ doctor and understanding the appointment process are crucial steps. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

SpeedWeed

AUGUST 9, 2021

The first supply of medical cannabis for pediatric patients with epilepsy at the Buenos Aires National Children’s Garrahan Hospital was finally delivered. The delivery was a long-awaited result of Law 27,350. The law was passed in 2017, but it wasn’t regulated until November of last year. It modified Law No. Shutterstock.

Epilepsy 52

Epilepsy Research and Development Medicine Patients 52

Veriheal

MAY 17, 2023

Singapore enforces some of the harshest drug laws on the planet and has faced immense pressure from all corners to banish the death penalty—a judicial law that claimed the lives of 11 people in 2021. After a two-year break, Singapore’s death penalty was reinforced in early 2022. grams of cannabis in 2017.

Research and Development 96

Research and Development Medicine Treatment Epilepsy 96

MMJ Recs

NOVEMBER 17, 2023

Licensing fees, taxes, and other revenue sources associated with MMJ operations generate income that can be reinvested in public services, healthcare initiatives, and community development. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JULY 2, 2021

Research Cluster with expert faculty members from various fields, as well as the first and only Drug Dependence Research Center in the country which is certified by the World Health Organization (WHO) Collaborating Center for Research and Training in Drug Dependence. Find investment partners and move ahead.

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

The Cannigma

MARCH 14, 2023

Those who were already under close watch by law enforcement because of structural racism, as well as those who were responsible for the well being of others had to be very careful about how they were perceived by those in control of the laws. 1 Of course, this risk was more intense for some than for others.

Policy 96

Policy Research and Development Conditions Consumption 96

United Patients Group

OCTOBER 25, 2023

However, despite state-level legalization, marijuana remains classified as a Schedule I drug under federal law, which means possessing, distributing, or selling it is still considered illegal by the federal government. What Conditions Can Medical Marijuana Treat? Can You Become Addicted to Medical Marijuana?

Marijuana 92

Marijuana Patients Research and Development Edibles 92

Veriheal

JANUARY 18, 2023

Research commissioned by the Centre for Medicinal Cannabis pinned a £1 billion valuation on the CBD market by the year 2025. This rare type of epilepsy caused her to endure up to 300 grand mal seizures per week from the tender age of five. Confusion surrounding British CBD laws has thrust the cannabinoid into a legal gray area.

CBD 94

CBD Strains Research and Development Oil 94

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. Patients should ensure compliance with local laws and regulations to access medical marijuana safely and legally.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

MARCH 30, 2019

Ministry of Health, Labor and Welfare officials recently announced the trials during a meeting of the Okinawa-Northern Task Force, a research and development agency. Epidiolex was crafted as a treatment for two forms of childhood epilepsy.

Clinical Trials 45

Clinical Trials Research and Development Epilepsy Environment 45

Cannabis Law Report

JANUARY 16, 2022

Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland. Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Cannabis Law Report

DECEMBER 18, 2019

Notably, the increase comes after the company recently broke into the European pharma-market after getting green-lighted from the Irish Government to sell its phytocannabinoid-derived “CannEpil” product to epilepsy sufferers. Both products are proprietary medicinal drugs developed internally through MGC’s research and development divisions.

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

MMJ Recs

MAY 29, 2024

Medical cannabis offers a promising alternative, with research indicating its efficacy in alleviating a wide range of symptoms associated with various medical conditions. Qualified patients are exempt from criminal prosecution for possession and use of medical marijuana within the limits set by law. Image by Iñaki del Olmo on Unsplash.

Marijuana 52

Marijuana Programs Patients Conditions 52

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! government classified all cannabis varieties, including hemp, as Schedule I under the Controlled Substances Act (despite decades of agricultural research detailing its differences from marijuana). What makes CBD special? In 1970, the U.S. CBD & Epidiolex.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

SEPTEMBER 6, 2021

The steadily aging population across the globe has played a significant role in driving the demand for medical cannabis as geriatric patients are more likely to develop chronic illnesses and require more physician visits. 12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

United Patients Group

FEBRUARY 8, 2023

Natural opioids include opium or poppy seeds; synthetic ones were first developed in 1950s by German chemist Paul Janssen, who went on to found Janssen Pharmaceutica NV (now part of Johnson & Johnson). Cannabinoids can be used to treat pain and inflammation, as well as other conditions such as epilepsy and multiple sclerosis (MS).

Chronic Pain 84

Chronic Pain Cannabinoids Research and Development Patients 84

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

MMJ Recs

MARCH 14, 2024

These conditions include, but are not limited to, cancer, epilepsy, multiple sclerosis, and PTSD, among others. Once registered, patients gain legal access to dispensaries across the state and are protected from prosecution for possessing and using medical marijuana in accordance with state law.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

JULY 25, 2022

This article will help you understand the laws in Pennsylvania. Although a lot of research is being conducted on the subject, no conclusive medical data has been provided to the medical community. One other main benefit of medical marijuana is that it presents very little side-effects and low risk of developing an addiction.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

MMJ Recs

DECEMBER 22, 2023

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). Other research suggests that extra-strength cannabis strains high in CBD may also help treat insomnia related specifically to post traumatic stress disorder (PTSD).

Blood Pressure 104

Blood Pressure Sleep Chronic Pain Digestion 104

Cannabis Law Report

JANUARY 27, 2022

Tilray has been on the Australian scene for quite some time – since at least since 2017 when twenty-nine Victorian children with very serious intractable epilepsy received a Tilray cannabidiol-based oral solution.

Education 52

Education Research and Development Medicine Epilepsy 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. The recent years have seen drastic marijuana law changes in several states. Cannabis Legalization Throughout The Country. Dravet Syndrome.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Severe treatment-resistant epilepsy. 1.4 Severe treatment-resistant epilepsy. NICE has made research recommendations on the use of cannabis-based medicinal products for severe treatment-resistant epilepsy. potential impact on structural and functional brain development.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

MAY 7, 2019

Marijuana is legal in each state, however, marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change. Liht’s business is conducted in a manner consistent with state law and is in compliance with licensing requirements. Veritas Pharma Inc.

Compliance 63

Compliance Compliance Research and Development Strains 63

The Joint Blog

JULY 4, 2023

While people may primarily use it to induce a psychoactive effect, modern research has revealed its well-known therapeutic benefits. Today, as laws around cannabis become more progressive and industry innovations make strides in every area, from medical application to recreational enjoyment, knowledge about cannabis is spreading fast.

Sleep 52

Sleep Research and Development Food Conditions 52

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Research Methodology. Research Scope And Assumptions. Recent Developments & Impact Analysis, By Key Market Participants. Market Outlook.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52